Carver Bancorp Leads 3 Noteworthy US Penny Stocks

Amid a market rebound following a Federal Reserve-induced downturn, U.S. stocks have shown resilience with the Dow Jones, S&P 500, and Nasdaq Composite each gaining ground. Penny stocks may be considered an outdated term by some, yet they remain relevant as investment opportunities for those seeking growth in smaller or newer companies. When these stocks are supported by strong balance sheets and solid fundamentals, they can offer potential upside while mitigating some of the risks typically associated with this segment of the market.

Advertisement

Top 10 Penny Stocks In The United States

NameShare PriceMarket CapFinancial Health RatingInter & Co (NasdaqGS:INTR)$3.95$1.93B★★★★☆☆BAB (OTCPK:BABB)$0.905$6.59M★★★★★★QuantaSing Group (NasdaqGM:QSG)$3.08$108.87M★★★★★★Imperial Petroleum (NasdaqCM:IMPP)$2.78$87.36M★★★★★★ZTEST Electronics (OTCPK:ZTST.F)$0.21$8.8M★★★★★★Permianville Royalty Trust (NYSE:PVL)$1.445$47.52M★★★★★★Golden Growers Cooperative (OTCPK:GGRO.U)$4.50$67.38M★★★★★★Smith Micro Software (NasdaqCM:SMSI)$0.9632$17.69M★★★★★☆CBAK Energy Technology (NasdaqCM:CBAT)$0.80$77.26M★★★★★☆Safe Bulkers (NYSE:SB)$3.58$381.2M★★★★☆☆

Click here to see the full list of 739 stocks from our US Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Carver Bancorp (NasdaqCM:CARV)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Carver Bancorp, Inc. is the holding company for Carver Federal Savings Bank, offering consumer and commercial banking services to a variety of clients primarily in New York, with a market cap of $9.30 million.

Operations: Carver Bancorp generates revenue of $28.32 million from its consumer and commercial banking services segment.

Market Cap: $9.3M

Carver Bancorp, Inc. faces significant challenges as a penny stock with a market cap of US$9.30 million and ongoing unprofitability, reporting losses of US$2.11 million in the recent quarter. Despite reducing losses by 7.3% annually over five years, it struggles with high bad loans at 2.8%. The company's board recently saw changes driven by activist investor Dream Chasers Capital Group LLC, which criticized past leadership for substantial shareholder value destruction and advocated for new directors to restore growth and profitability while maintaining Carver's community role in New York's underserved areas.

NasdaqCM:CARV Financial Position Analysis as at Dec 2024
NasdaqCM:CARV Financial Position Analysis as at Dec 2024

Gulf Resources (NasdaqGS:GURE)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Gulf Resources, Inc. operates through its subsidiaries in the People's Republic of China, focusing on the manufacture and trading of bromine, crude salt, chemical products, and natural gas with a market cap of $6.93 million.

Operations: The company's revenue is primarily derived from its bromine segment at $10.76 million, followed by crude salt at $1.98 million, and natural gas and brine contributing $0.06 million.

Market Cap: $6.93M

Gulf Resources, Inc. is experiencing financial difficulties, with a significant decline in sales to US$5.93 million for the first nine months of 2024 compared to US$23.17 million a year ago and escalating losses totaling US$40.58 million over the same period. The company has been issued a Nasdaq Deficiency Letter due to its stock price falling below the minimum bid requirement of $1 per share, risking delisting if compliance isn't regained by May 2025. Despite having seasoned management and no debt, Gulf Resources faces volatility and liquidity challenges with less than one year of cash runway remaining.

NasdaqGS:GURE Debt to Equity History and Analysis as at Dec 2024
NasdaqGS:GURE Debt to Equity History and Analysis as at Dec 2024

Telesis Bio (OTCPK:TBIO)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Telesis Bio, Inc. is a synthetic biology company that manufactures and sells instruments, reagents, and related services to pharmaceutical and academic laboratories globally, with a market cap of $1.19 million.

Operations: The company's revenue is derived entirely from its Scientific & Technical Instruments segment, generating $17.03 million.

Market Cap: $1.19M

Telesis Bio, Inc. faces challenges typical of penny stocks, with declining revenue to US$5.31 million for the first nine months of 2024 from US$15.78 million a year prior and persistent losses totaling US$27.86 million over the same period. Despite a satisfactory net debt to equity ratio of 34.2%, its short-term assets fall short of covering long-term liabilities, indicating financial strain exacerbated by recent shareholder dilution and high volatility in share price. The company recently raised US$3 million through promissory notes to extend its cash runway beyond two months, reflecting ongoing capital needs amidst executive changes and market index removal concerns.

OTCPK:TBIO Financial Position Analysis as at Dec 2024
OTCPK:TBIO Financial Position Analysis as at Dec 2024

Make It Happen

  • Take a closer look at our US Penny Stocks list of 739 companies by clicking here.
  • Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
  • Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:GURE

Gulf Resources

Through its subsidiaries, manufactures and trades in bromine and crude salt in the People’s Republic of China.

Moderate risk with adequate balance sheet.

Advertisement

Weekly Picks

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.9% undervalued
23 users have followed this narrative
2 users have commented on this narrative
17 users have liked this narrative
TO
Tokyo
MC logo
Tokyo on LVMH Moët Hennessy - Louis Vuitton Société Européenne ·

EU#4 - Turning Heritage into the World’s Strongest Luxury Empire

Fair Value:€750.0429.5% undervalued
4 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
GOOGL logo
WealthAP on Alphabet ·

The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story

Fair Value:US$386.4312.1% undervalued
57 users have followed this narrative
1 users have commented on this narrative
16 users have liked this narrative

Updated Narratives

TA
Talos
AMD logo
Talos on Advanced Micro Devices ·

The "David vs. Goliath" AI Trade – Why Second Place is Worth Billions

Fair Value:US$441.5845.2% undervalued
21 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FH
SOF logo
fhuyge on Sofina Société Anonyme ·

Why I invest in Sofina (Dividend growth)

Fair Value:€332.3828.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ID
VNOM logo
Idle on Viper Energy ·

Great dividend but share numbers have increased 100% in last 12 months!!

Fair Value:US$32.9926.9% overvalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8249.1% undervalued
85 users have followed this narrative
6 users have commented on this narrative
35 users have liked this narrative
OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3320.9% undervalued
75 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0228.7% undervalued
1050 users have followed this narrative
6 users have commented on this narrative
31 users have liked this narrative

Trending Discussion

HE
Hemingway
AEVA logo
Hemingway on Aeva Technologies ·

NVDA+AEVA Agreement is a game changer for the AEVA stock even though it is just a partnership and does not have a roll out until 2028 (which means receivables as early as 2027, I would imagine) This agreement effectively moves the goal posts of profitability for AEVA much closer since this is in addition to the recent Forterra agreement, as well as the (previously announced) European carmaker agreement (which is believed to be Mercedes-Benz and estimated to be worth at least 1 billion in sales alone) Underneath all of this, AEVA has a pre-existing agreement with Daimler Truck. So business seems to be booming, especially with really big name brands…which tends to bring in even more brand names (and thus more agreements/contracts/announcements, etc). This dynamic often creates more coverage from analysts (often with upside stock initial coverage) that I believe will be occurring over the next 3 to 6 months (as professional traders/analysts often research for 2 to 3 months before initiating coverage of a new issue). I also feel that the above momentum increases the likelihood that companies that do not currently utilize 4G LIDAR technology might consider buying AEVA outright. Realistically, even with a substantial premium to the current stock price, the cost of AEVA would be a rounding error for the likes of a company such as Tesla, and certainly would allow them to maintain their technological edge as the competition for self-driving vehicles continues to heat up. However, I think it is equally possible for NVidea to decide to lock-in the AEVA technology for their upcoming autonomous hardware/software package by buying them outright. Obviously, the above factors and recent activity in the AEVA stock are cause for optimism. Of course, this all just one opinion , so please do your own due diligence. Disclaimer: I/We DO trade in this stock from time to time and I/we may (or may not have) a position currently, so again, please do your own due diligence.

0
|
0
Advertisement